as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹145.83
Change
-0.64 (-0.44%)
Open
₹146.1
Prev. Close
₹146.47
Day High
₹148.54
Day Low
₹145.22
Volume Analysis
Traded
55,026
Delivered
30,691
Delivery %
55.78%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (0)
No signal for this stock
Opportunities (1)
- •Strong 3-year revenue growth (28.4%)
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹151.16 | ₹149.85 | ₹147.84 | ₹146.53 | ₹144.52 | ₹143.21 | ₹141.2 |
| Fibonacci | ₹149.85 | ₹148.58 | ₹147.8 | ₹146.53 | ₹145.26 | ₹144.48 | ₹143.21 |
| Camarilla | ₹146.74 | ₹146.44 | ₹146.13 | ₹146.53 | ₹145.53 | ₹145.22 | ₹144.92 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-25.02%
1 Week
-0.95%
1 Month
-1.17%
3 Months
-6.69%
6 Months
+2.44%
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹135.39
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
11.52%
Net margin 11.72% × asset turnover 0.63x × equity multiplier 1.56x
Company Overview
Sector
Healthcare
Market Cap
₹661 Cr
P/E (TTM)
13.6
ROE
12.5%
Book Value
₹94.4
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.
TopFund Analysis
Fabtech Technologies Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 53/100. The strongest factor is Financial Strength (100/100), while Cash Flow (13/100) is the weakest area to weigh before deciding. Strong 3-year revenue growth (28.4%).
TopFund Score — Fundamentals Quality
53/100 — AverageData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has delivered good profit growth of 35.8% CAGR over last 5 years
- −Earnings include an other income of Rs.23.3 Cr.
- −Company has high debtors of 182 days.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Fabtech will meet investors/analysts in Mumbai on 24 Sept 2026 through Kaptify Consulting.
Fabtech won a INR 21 crore turnkey project in a CIS country for a medical-device facility.
FTS Cleanrooms Systems completes 14,000 sqm Himalaya Wellness facility in UAE under a year.
Fabtech AGM resolutions passed, including Rs 0.60 final dividend, material RPT, and director reappointment.
AGM approved Amjad Adam Arbani’s reappointment and Naushad Panjwani’s five-year independent director term.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 59 | 104 | 135 | 68 | 121 | 63 | 159 | 75 |
| Expenses + | 54 | 81 | 117 | 74 | 91 | 74 | 136 | 71 |
| Operating Profit | 5 | 23 | 18 | -6 | 30 | -12 | 22 | 4 |
| OPM % | 7.81% | 21.92% | 13.61% | -9.13% | 25.07% | -18.48% | 14.01% | 5.65% |
| Other Income + | 2 | 2 | 3 | 3 | 3 | 7 | 10 | 3 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 6 | 24 | 20 | -6 | 31 | -7 | 30 | 5 |
| Tax % | 14.81% | 12.98% | 24.23% | -1.13% | 10.08% | -15.12% | 26.23% | 19.69% |
| Net Profit + | 5 | 20 | 15 | -6 | 28 | -6 | 22 | 4 |
| EPS in Rs | 2 | 6 | 5 | -2 | 9 | -1 | 5 | 1 |
| Raw PDF | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 133 | 121 | 257 | 194 | 226 | 327 | 411 | 418 |
| Expenses + | 119 | 110 | 225 | 169 | 191 | 288 | 376 | 372 |
| Operating Profit | 14 | 11 | 32 | 25 | 35 | 39 | 35 | 45 |
| OPM % | 11.0% | 9.0% | 12.0% | 13.0% | 15.0% | 12.0% | 9.0% | 11.0% |
| Other Income + | 5 | 2 | 4 | 10 | 6 | 27 | 23 | 23 |
| Interest | 2 | 2 | 3 | 5 | 3 | 3 | 4 | 4 |
| Depreciation | 0 | 0 | 2 | 2 | 2 | 3 | 5 | 5 |
| Profit before tax | 16 | 11 | 31 | 28 | 36 | 60 | 48 | 60 |
| Tax % | 27.0% | 29.0% | 25.0% | 22.0% | 24.0% | 23.0% | 21.0% | — |
| Net Profit + | 12 | 8 | 23 | 22 | 27 | 46 | 38 | 49 |
| EPS in Rs | 12,390 | 8,040 | 84 | 78 | 92 | 14 | 9 | 13 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 7.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Reserves | 38 | 46 | 65 | 86 | 129 | 141 | 375 |
| Borrowings + | 1 | 9 | 21 | 35 | 13 | 84 | 70 |
| Other Liabilities + | 84 | 70 | 83 | 89 | 125 | 170 | 164 |
| Total Liabilities | 123 | 126 | 172 | 214 | 269 | 427 | 654 |
| Fixed Assets + | 2 | 2 | 5 | 4 | 22 | 94 | 78 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 12 | 7 | 17 | 20 | 21 | 15 | 26 |
| Other Assets + | 109 | 116 | 150 | 190 | 226 | 318 | 550 |
| Total Assets | 123 | 126 | 172 | 214 | 269 | 427 | 654 |
| Equity Capital | 0 | 0 | 3 | 3 | 3 | 32 | 44 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 64 | -9 | -3 | -14 | 60 | -36 | 0 |
| Cash from Investing Activity + | -28 | 4 | -9 | 2 | -30 | -20 | -112 |
| Cash from Financing Activity + | -23 | 6 | 8 | 12 | -12 | 36 | 190 |
| Net Cash Flow | 13 | 1 | -4 | 0 | 18 | -20 | 78 |
| CFO/OP | 417 | -65 | 4 | -15 | 196 | -68 | 36 |
| Free Cash Flow | 64 | -9 | -4 | -14 | 59 | -61 | 5 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Public | 29.04% | 28.83% | 28.57% |
| Promoters | 68.94% | 68.94% | 68.94% |
| FII | 0.03% | 0.08% | 0.02% |
| DII | 1.99% | 2.15% | 2.45% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Fabtech Technologies Ltd (this stock) | 661 | 13.6 | 1.58 | 12.5% |
| Valiant Laboratories Ltd | 678 | 42.4 | 2.19 | -1.2% |
| Zim Laboratories Limited | 716 | 194.0 | 2.42 | 1.59% |
| Wanbury Limited | 784 | 18.2 | 12.38 | 76.5% |
| Kilitch Drugs India Ltd | 786 | 26.2 | 2.81 | 10.6% |
| Gaudium Ivf N Women H L | 837 | 36.2 | 5.55 | 24.7% |
| Bafna Pharmaceuticals Ltd | 842 | — | 1.65 | -6.18% |
Which Mutual Funds Hold Fabtech Technologies Ltd?
Frequently Asked Questions about Fabtech Technologies Ltd
Fabtech Technologies Ltd (FABTECH) closed at ₹145.83 on NSE on 25 September 2026, down 0.64 (0.44%) from the previous close.
Fabtech Technologies Ltd trades on the NSE (National Stock Exchange of India) under the symbol FABTECH.
Fabtech Technologies Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 13.6.
Fabtech Technologies Ltd has a dividend yield of 0.4%.
Fabtech Technologies Ltd's 52-week high is ₹263.0 and its 52-week low is ₹126.0.
Fabtech Technologies Ltd has a market capitalisation of ₹661 crore.
Fabtech Technologies Ltd has a TopFund Quality Score of 53/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Fabtech Technologies Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.